Alternatives to animal testing have advanced dramatically in recent decades, and their adoption is accelerating through regulatory, commercial, and scientific pressure.
Alternatives to animal testing represent a convergence of welfare, scientific, and economic interests. Many animal models poorly predict human responses — failing to translate in ways that have contributed to costly clinical trial failures. Human cell lines, organoids, organ-on-chip devices, and computational models often provide better human-relevant data alongside eliminating animal welfare costs. Regulatory acceptance of alternatives has been the primary bottleneck, but this is changing rapidly through coordinated international effort. Investment in alternatives technology and regulatory validation is one of the highest-leverage research animal welfare interventions.